In recent years, nanoscience and nanotechnology have emerged as promising fields in materials science.

Nanoflowers, which are flower-shaped nanomaterials, have attracted significant attention from scientists due to their unique morphologies, facile synthetic methods, and physicochemical properties such as a high surface-to-volume ratio, enhanced charge transfer and carrier immobility, and an increased surface reaction efficiency. Nanoflowers can be synthesized using inorganic or organic materials, or a combination of both (called a hybrid), and are mainly used for biomedical applications. Thus far, researchers have focused on hybrid nanoflowers and only a few studies on inorganic nanoflowers have been reported. For the first time in the literature, we have consolidated all the reports on the biomedical applications of inorganic nanoflowers in this review. Herein, we review some important inorganic nanoflowers, which have applications in antibacterial treatment, wound healing, combinatorial cancer therapy, drug delivery, and biosensors to detect diseased conditions such as diabetes, amyloidosis, and hydrogen peroxide poisoning. In addition, we discuss the recent advances in their biomedical applications and preparation methods. Finally, we provide a perspective on the current trends and potential future directions in nanoflower research. The development of inorganic nanoflowers for biomedical applications has been limited to date. Therefore, a diverse range of nanoflowers comprising inorganic elements and materials with composite structures must be synthesized using ecofriendly synthetic strategies.

Polyurethane foams (PUFs) have attracted attention as biomaterials because of their low adhesion to the wound area and suitability as biodegradable or bioactive materials. The composition of the building blocks for PUFs can be controlled with additives, which provide excellent anti-drug resistance and biocompatibility. Herein, nanosized Cu-BTC (copper(II)-benzene-1,3,5-tricarboxylate) was incorporated into a PUF via the crosslinking reaction of castor oil and chitosan with toluene-2,4-diisocyanate, to enhance therapeutic efficiency through the modification of the surface of PUF. The physical and thermal properties of the nanosized Cu-BTC-incorporated PUF (PUF@Cu-BTC), e.g., swelling ratio, phase transition, thermal gravity loss, and cell morphology, were compared with those of the control PUF. The bactericidal activities of PUF@Cu-BTC and control PUF were evaluated against Pseudomonas aeruginosa, Klebsiella pneumoniae, and methicillin-resistant Staphylococcus aureus. PUF@Cu-BTC exhibited selective and significant antibacterial activity toward the tested bacteria and lower cytotoxicity for mouse embryonic fibroblasts compared with the control PUF at a dose of 2 mg mL⁻¹. The Cu(II) ions release test showed that PUF@Cu-BTC was stable in phosphate buffered saline (PBS) for 24 h. The selective bactericidal activity and low cytotoxicity of PUF@Cu-BTC ensure it is a candidate for therapeutic applications for the drug delivery, treatment of skin disease, and wound healing.

Crystalline metal–organic frameworks (MOFs) are extensively used in areas such as gas storage and small-molecule drug delivery. Although Cu-BTC (1, MOF-199, BTC: benzene-1,3,5-tricarboxylate) has versatile applications, its NO storage and release characteristics are not amenable to therapeutic usage. In this work, micro-sized Cu-BTC was prepared solvothermally and then processed by ball-milling to prepare nano-sized Cu-BTC (2). The NO storage and release properties of the micro- and nano-sized Cu-BTC MOFs were morphology dependent. Control of the hydration degree and morphology of the NO delivery vehicle improved the NO release characteristics significantly. In particular, the nano-sized NO-loaded Cu-BTC (NO⊂nano-Cu-BTC, 4) released NO at 1.81 µmol·mg⁻¹ in 1.2 h in PBS, which meets the requirements for clinical usage. The solid-state structural formula of NO⊂Cu-BTC was successfully determined to be [CuC₆H₂O₅]·(NO)_0.167 through single-crystal X-ray diffraction, suggesting no structural changes in Cu-BTC upon the intercalation of 0.167 equivalents of NO within the pores of Cu-BTC after NO loading. The structure of Cu-BTC was also stably maintained after NO release. NO⊂Cu-BTC exhibited significant antibacterial activity against six bacterial strains, including Gram-negative and positive bacteria. NO⊂Cu-BTC could be utilized as a hybrid NO donor to explore the synergistic effects of the known antibacterial properties of Cu-BTC.

Perhydropolysilazane (PHPS) has attracted considerable attention as a versatile precursor for solution-processed silicon-based materials because of its carbon-free backbone, high chemical reactivity, and compatibility with low-temperature processing. This review provides a comprehensive overview of the synthesis of PHPS, its conversion routes and mechanisms, the structure–property relationships of PHPS-derived materials, and their current and emerging applications. The literature demonstrates that PHPS conversion is governed by coupled hydrolysis, oxidation, nitridation, dehydrogenation, photochemical activation, and reactive-species-mediated processes, resulting in compositionally and structurally diverse silicon-based networks, including SiO_x-rich, SiO_xNᵧ, and SiN_x materials. The resulting optical, mechanical, surface, and barrier properties are determined by network structure, residual bonding environments, compositional gradients, and interfacial characteristics rather than by the nominal conversion method alone. Recent advances further demonstrate the potential of PHPS-derived materials for barrier coatings, dielectric and interfacial layers, protective coatings, semiconductor processing, and high-temperature ceramic applications. Overall, PHPS should be regarded not merely as a silica precursor but as a tunable preceramic platform for engineering diverse silicon-based networks. Future progress will depend on predictive control of conversion processes, standardized evaluation protocols, sustainable solution-based manufacturing, and comprehensive device-level validation to facilitate practical implementation.